The study
Tesamorelin — Efficacy and Safety Study of Tesamorelin in Chronic Obstructive Pulmonary Disease (COPD) Subjects With Muscle Wasting
What it testedchronic obstructive pulmonary disease (COPD)
Size3 participants — small enough that almost no conclusion survives it
StagePhase 2
Statusstopped early
NCT01388920 on ClinicalTrials.gov
Claim of the week
GHRP-6
Sold for:
- "Muscle growth"
- "Fat loss"
- "Recovery"
- "Appetite / bulking"
On record: No registered human trials in the registries we track. Not one.
On the horizon
Studies now recruiting. None of these have results yet — they are the questions being asked, and the reason these numbers will change.
- BPC-157 — hamstring muscle strain, skeletal muscle injury
Phase 2 · 120 participants · NCT07437547
- GHK-Cu — ghk and ghk-cu blood levels
unphased · 100 participants · NCT07706361
- Melanotan II — nonsegmental vitiligo, nonsegmental vitiligo (stable)
Phase 2 · 60 participants · NCT07437560
- MOTS-c — prediabetes, insulin resistance
Phase 2 · 120 participants · NCT07505745
Worth knowing
Why "research use only" is on the label
It is not a quality tier and it is not a legal shield for you. It is the phrase that lets a seller ship an unapproved drug without formally saying it is for humans. The label is about their liability, not your safety.